Preventing respiratory syncytial virus in homebound premature infants.
This article explores the home health nurse's role in preventing respiratory syncytial virus (RSV) among premature infants. Thousands of children infected with RSV require hospitalization each year. Consistent contact with the infant alerts the nurse to subtle signs and symptoms of RSV infection, which may include nasal congestion, cough, low-grade fever, and malaise. By developing patient and caregiver trust, the home health nurse can implement an RSV prevention plan, leading to a decrease in hospitalization episodes of premature infants with RSV. Identification of patient risk factors contributing to RSV together with caregiver education is addressed in this article.
Woman's Home Care, Baton Rouge, LA 70817, USA. jraustin5@hotmail.com
Jennifer
J
Austin
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000627:therapeutic use; D003152:Community Health Nursing / Q000458:organization & administration*; D006235:Hand Disinfection; D006699:Home Care Services / Q000458:organization & administration*; D018577:Homebound Persons; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000453:epidemiology / Q000517:prevention & control*; D017053:Infection Control / Q000458:organization & administration*; D024802:Nurse's Role; D009730:Nursing Assessment; D000069455:Palivizumab; D010290:Parents / Q000193:education / Q000523:psychology; D010347:Patient Care Planning; D018579:Patient Selection; D011368:Professional-Family Relations; D018357:Respiratory Syncytial Virus Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D012307:Risk Factors; D014028:Tobacco Smoke Pollution / Q000009:adverse effects / Q000517:prevention & control; D035502:Trust; D014789:Visitors to Patients
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D014028:Tobacco Smoke Pollution; D000069455:Palivizumab